Aptose to Report Second Quarter 2023 Financial Results and Hold Conference Call on Thursday, August 10, 2023
Author of the article: Published Jul 27, 2023 • 2 minute read SAN DIEGO and TORONTO, July 27, 2023 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the…
bubmagJuly 27, 2023